Can ixekizumab therapy lead to sustained remission or disease modification in patients with psoriasis?

Featuring Joel Gelfand, MD, MSCE, FAAD |

Penn Medicine

Director, Psoriasis and Phototherapy Treatment Center

Director, Center for Clinical Sciences in Dermatology

Philadelphia, Pennsylvania

| Published November 01, 2024